Trupanion (NASDAQ:TRUP – Get Free Report) is scheduled to post its quarterly earnings results after the market closes on Thursday, May 2nd. Analysts expect Trupanion to post earnings of ($0.18) per share for the quarter. Individual interested in registering for the company’s earnings conference call can do so using this link.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its quarterly earnings data on Thursday, February 15th. The financial services provider reported ($0.05) EPS for the quarter, beating analysts’ consensus estimates of ($0.18) by $0.13. The firm had revenue of $295.50 million for the quarter, compared to analyst estimates of $289.84 million. Trupanion had a negative return on equity of 15.19% and a negative net margin of 4.03%. The business’s quarterly revenue was up 20.1% compared to the same quarter last year. During the same period last year, the company earned ($0.23) EPS. On average, analysts expect Trupanion to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Trupanion Stock Down 6.3 %
Shares of TRUP opened at $22.50 on Wednesday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.42. The business’s fifty day moving average price is $25.68 and its two-hundred day moving average price is $26.81. Trupanion has a 52 week low of $18.45 and a 52 week high of $37.71.
Wall Street Analyst Weigh In
Read Our Latest Report on Trupanion
About Trupanion
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
Further Reading
- Five stocks we like better than Trupanion
- How to Start Investing in Real Estate
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Why Are Stock Sectors Important to Successful Investing?
- Hilton Demonstrates Asset Light is Right for Investors
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.